Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever

Sponsor
University of Massachusetts, Worcester (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02134652
Collaborator
(none)
0
1
17
0

Study Details

Study Description

Brief Summary

The purpose of this study is determine the ability of bedide ultrasound performed in the Emergency Department and Outpatient Department can predict the severity of disease during a Dengue Fever outbreak in children, in Siem Reap, Cambodia. Our hypothesis is that the presence of gallbladder wall thickening and/or pleural effusions in children correlates with progression to Dengue hemorrhagic fever and Dengue shock. In addition, we hypothesize that sonographic imaging of pediatric patients presenting to the emergency department with a fever during a Dengue fever outbreak will change management and disposition.

Condition or Disease Intervention/Treatment Phase
  • Other: diagnostic bedside ultrasound

Detailed Description

Dengue fever has various levels of severity, from mild disease to severe hemorrhagic complications and shock. Dengue is endemic world-wide and has been found in the United States. The mortality from dengue fever can be as high as 15-20%, with nearly 22,000 deaths annually, most of them children (Reddy, 2013). There is no reliable way to immediately predict which children presenting with a fever during a Dengue fever outbreak will progress to more severe disease. Some children with dengue fever will improve with limited clinical interventions, but others require intensive therapy. Limited healthcare resources in developing countries make decisions on treatment or disposition difficult as many children and poor clinical decision increase morbidity and mortality. In more developed countries such as the United States, early identification of patients with dengue fever has the potential to identify children who may benefit from early interventions. Identifying those patients is the first step in exploring early therapies to effect mortality. Previous research has demonstrated that intrathoracic/ peritoneal fluid and gallbladder wall thickening is associated with worsening of the clinical prognosis for hospitalized patients with dengue fever (Michels, 2013). We will explore earlier presentations in the emergency department and outpatient department.

Our hypothesis is that the presence of gallbladder wall thickening and/or pleural effusions in children correlates with progression to Dengue hemorrhagic fever and Dengue shock. In addition, we hypothesize that sonographic imaging of pediatric patients presenting to the emergency department with a fever during a Dengue fever outbreak will change management and disposition. Our specific aim is to 1) compare the accuracy of bedside ultrasound detection of intra-thoracic fluid, peritoneal free fluid, and gallbladder wall thickening and physical exam versus physical exam alone in diagnosing dengue fever and 2) determine the association between sonographic features of dengue (intra-thoracic fluid and gallbladder wall thickening) and clinical outcome in children with dengue fever.

This study is a prospective observational clinical study in the emergency department, inpatient ward, intensive care unit, and outpatient department of the Angkor Hospital for Children in Siem Reap, Cambodia. Study subjects will include children 16 years or less, who present during the annual Dengue Fever outbreak with suspected Dengue fever. Subjects include children with an acute febrile illness, and two of the following: headache, retro-orbital pain, myalgias, arthralgia, rash, hemorrhagic manifestations, or plasma leakage (i.e. shortness of breath, abdominal distention/pain). Clinicians will determine their clinical suspicion of dengue, intended therapeutic interventions and disposition following a history and physical exam but before ultrasound imaging. Study personnel will perform diagnostic bedside ultrasound imaging of the gallbladder and peritoneal and pleural spaces (FAST exam) and the clinician again determine their clinical suspicion of Dengue, intended therapeutic interventions and disposition. Patients will be followed to determine clinical outcome, therapeutic interventions and disposition. The primary endpoint is progression of disease. The secondary endpoint will be change in clinical care provided in the emergency department related to ultrasound imaging.

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Time Perspective:
Prospective
Official Title:
Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
Study Start Date :
Jan 1, 2015
Anticipated Primary Completion Date :
Jun 1, 2016
Anticipated Study Completion Date :
Jun 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Suspected Dengue

Children with an acute febrile illness, and two of the following: headache, retro-orbital pain, myalgias, arthralgia, rash, hemorrhagic manifestations, or plasma leakage (i.e. shortness of breath, abdominal distention/pain) will all receive a diagnostic bedside ultrasound.

Other: diagnostic bedside ultrasound
Patients enrolled in this study will undergo bedside ultrasound during their initial presentation to the emergency department. Ultrasound imaging protocols include the following: FAST Exam - Standard images will be obtained using the abdominal transducer. Images include the following: 1) sub-xyphoid 2)right upper quadrant (with right thorax) 3)left upper quadrant (with left thorax) and 4) suprapubic Right Upper Quadrant Exam - Standard images will be obtained using the abdominal transducer. Images include the following: 1) Long axis of the gallbladder 2) Transverse axis of the gallbladder fundus 3) Transverse axis of the gallbladder body and 4) Transverse axis of the gallbladder neck.

Outcome Measures

Primary Outcome Measures

  1. Progression of Disease [Patients who are discharged from home will be contacted a maximum of 10 days after discharge to acquire follow up data. Those patients who are admitted to the hospital will monitored for the entirety of their hospital stay, an average of about 2 weeks.]

    Changes in clinical course or progression of disease in patients with Dengue Fever or Dengue Hemorrhagic Fever

Secondary Outcome Measures

  1. Clinical Care [Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for changes in decision making.]

    Change in clinical care provided in the emergency department related to ultrasound imaging for patients presenting to the emergency department with symptoms of Dengue Fever.

Other Outcome Measures

  1. Disposition [Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for decision to admit versus discharge.]

    Change in disposition related to ultrasound imaging in patients presenting to the emergency department with symptoms of Dengue Fever

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Months to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age >3 months and <16 years

  2. Clinical suspicion of dengue hemorrhagic fever. (Revised WHO Classification System)

  3. Not a prisoner or ward of the state

  4. Parents able and willing to give consent. Children older then 7 able and willing to give assent

Exclusion Criteria:
  1. Allergic to Ultrasound gel

  2. Prisoners or wards of the state

  3. Unstable patients

  4. Known pleural effusion, ascites, or gallbladder wall thickening.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Angkor Hospital for Children Siem Reap Cambodia

Sponsors and Collaborators

  • University of Massachusetts, Worcester

Investigators

  • Principal Investigator: Samuel D Licciardo, M.D., University of Massachusetts, Worcester
  • Study Chair: Romolo Gaspari, M.D., Ph.D., University of Massachusetts, Worcester

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Massachusetts, Worcester
ClinicalTrials.gov Identifier:
NCT02134652
Other Study ID Numbers:
  • EUS-3325
First Posted:
May 9, 2014
Last Update Posted:
Jun 11, 2015
Last Verified:
Jun 1, 2015
Keywords provided by University of Massachusetts, Worcester
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 11, 2015